106 Participants Needed

Hip Arthroscopy with Periacetabular Osteotomy for Hip Dysplasia

CW
LC
Overseen ByLauren Cole
Age: < 65
Sex: Any
Trial Phase: Academic
Sponsor: Mayo Clinic
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

The study will assess the outcomes of patients treated with concomitant hip arthroscopy at the time of periacetabular osteotomy (PAO) for patients with hip dysplasia compared with patients treated with PAO alone.

Do I need to stop my current medications for the trial?

The trial information does not specify whether you need to stop taking your current medications.

What data supports the effectiveness of the treatment Periacetabular osteotomy combined with hip arthroscopy for hip dysplasia?

Research shows that the Bernese periacetabular osteotomy (PAO) is effective for treating hip dysplasia by reorienting the hip socket, and combining it with hip arthroscopy can address additional hip joint issues. Studies have reported positive intermediate-term outcomes and patient satisfaction with this combined approach.12345

Is hip arthroscopy with periacetabular osteotomy generally safe for humans?

Periacetabular osteotomy (PAO), including its combination with hip arthroscopy, is generally considered safe, but there are some risks. Studies have reported complications such as femoroacetabular impingement (a condition where bones in the hip joint rub against each other) and other surgical risks, which can vary based on the surgical approach used.12678

How does the treatment of hip arthroscopy with periacetabular osteotomy for hip dysplasia differ from other treatments?

This treatment is unique because it combines hip arthroscopy (a minimally invasive procedure to look inside the joint) with periacetabular osteotomy (a surgery to correct the hip socket's position) to address both the bone structure and any joint issues in patients with hip dysplasia, offering a comprehensive approach to treatment.13459

Research Team

Rafael J. Sierra, M.D. - Doctors and ...

Rafael Sierra, MD

Principal Investigator

Mayo Clinic

Eligibility Criteria

This trial is for individuals aged 15-55 with hip dysplasia, specifically Developmental Dysplasia of the Hip (DDH), who are skeletally mature and have minimal or no arthritis. They must be able to undergo a preoperative MRI arthrogram of the hip. Pregnant women, those with previous hip surgeries, or patients treated for acetabular retroversion without DDH cannot participate.

Inclusion Criteria

I have hip dysplasia and am choosing surgery (PAO) for treatment.
My arthritis is mild or nonexistent.
My bones have stopped growing.
See 2 more

Exclusion Criteria

I am getting PAO surgery for hip socket misalignment without having developmental hip dysplasia.
I have had hip surgery to treat joint problems.
I have had surgery on my hip before.
See 1 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Surgery

Participants undergo periacetabular osteotomy with or without hip arthroscopy

1 day
1 visit (in-person)

Follow-up

Participants are monitored for safety and effectiveness after surgery

1 year
Multiple visits (in-person)

Treatment Details

Interventions

  • Periacetabular osteotomy
  • Periacetabular osteotomy with hip arthroscopy
Trial OverviewThe study compares two treatments for hip dysplasia: one group will receive Periacetabular Osteotomy (PAO) alone, while another group will get PAO combined with hip arthroscopy. The goal is to see which treatment leads to better outcomes in terms of joint function and pain relief.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Periacetabular osteotomyExperimental Treatment1 Intervention
Standard periacetabular osteotomy on the day of surgery.
Group II: Periacetabular osteotomy with hip arthroscopyActive Control1 Intervention
Hip arthroscopy on the day of surgery, followed by a standard periacetabular osteotomy.

Periacetabular osteotomy is already approved in European Union, United States, Switzerland for the following indications:

πŸ‡ͺπŸ‡Ί
Approved in European Union as PAO for:
  • Hip dysplasia
  • Developmental dysplasia of the hip (DDH)
  • Femoroacetabular impingement (FAI)
πŸ‡ΊπŸ‡Έ
Approved in United States as PAO for:
  • Hip dysplasia
  • DDH
  • FAI
  • Labral tears
πŸ‡¨πŸ‡­
Approved in Switzerland as PAO for:
  • Hip dysplasia
  • DDH
  • FAI

Find a Clinic Near You

Who Is Running the Clinical Trial?

Mayo Clinic

Lead Sponsor

Trials
3,427
Recruited
3,221,000+

Findings from Research

In a review of 40 studies involving 4070 hips, Bernese periacetabular osteotomy (PAO) showed good to excellent outcomes in 82% of cases, with a lower complication rate of 7% compared to previous reports.
Minimally invasive surgical approaches, such as the modified Smith-Petersen and trans-sartorial techniques, were associated with significantly reduced rates of nerve injuries and major wound complications, making them preferable options for this procedure.
Complications and outcome after periacetabular osteotomy - influence of surgical approach.Ali, M., Malviya, A.[2022]
The Bernese periacetabular osteotomy (PAO) showed a high hip survival rate of 92% at 15 years post-surgery, indicating its effectiveness as a treatment for symptomatic acetabular dysplasia in 154 hips evaluated after an average of 10.3 years.
Factors such as fair or poor preoperative joint congruency and excessive postoperative femoral head coverage increased the risk of failure, while performing a concurrent head-neck osteochondroplasty reduced this risk, highlighting important considerations for surgical outcomes.
Intermediate-Term Hip Survivorship and Patient-Reported Outcomes of Periacetabular Osteotomy: The Washington University Experience.Wells, J., Schoenecker, P., Duncan, S., et al.[2022]
In a study of 17 patients undergoing simultaneous hip arthroscopy and periacetabular osteotomy (PAO) for acetabular dysplasia, 82% achieved excellent outcomes with significant improvements in pain and function over an average follow-up of 2.4 years.
All patients had chondrolabral damage, which was treated during the procedure, and no patients required conversion to total hip arthroplasty or revision surgery, indicating that this combined approach is both effective and safe.
Concomitant Hip Arthroscopy and Periacetabular Osteotomy.Domb, BG., LaReau, JM., Hammarstedt, JE., et al.[2022]

References

Complications and outcome after periacetabular osteotomy - influence of surgical approach. [2022]
Intermediate-Term Hip Survivorship and Patient-Reported Outcomes of Periacetabular Osteotomy: The Washington University Experience. [2022]
Concomitant Hip Arthroscopy and Periacetabular Osteotomy. [2022]
Combined Surgical Approach to Young Adults with Hip Dysplasia and Concomitant Intra-Articular Pathology Using Intra-Abdominal Monitoring. [2021]
The prevalence of hip labral and chondral lesions identified by method of detection during periacetabular osteotomy: arthroscopy versus arthrotomy. [2022]
Bernese periacetabular osteotomy in males: is there an increased risk of femoroacetabular impingement (FAI) after Bernese periacetabular osteotomy? [2021]
The association the patient-reported outcomes after periacetabular osteotomy with radiographic features: a short-term retrospective study. [2023]
Periacetabular osteotomy to treat hip dysplasia: a systematic review of harms and benefits. [2023]
Is intraarticular pathology common in patients with hip dysplasia undergoing periacetabular osteotomy? [2022]